Mandate

Vinge advises funds managed by Triton

November 13, 2017 Banking and Finance

Vinge has advised funds managed by Triton in connection with the acquisition of KEWAB, a supplementary acquisition to Akeab. KEWAB is a leading supplier of excavation services, facility and power supply work in western Sweden.

KEWAB and Akeab will be included as sister companies in an infrastructure group, focused on facility and construction work, owned by Triton and the management in the relevant company.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Oscar Rydén, Johanna Wiberg and Michaela Cronemyr. Partner Albert Wållgren and associates Linn Adelwald and André Isacson provided financing advice. Partner Marcus Glader and associates Xandra Ståhlberg and Annika Nyberg Ekenberg provided competition law advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026